Norma Gutierrez
Overview
Explore the profile of Norma Gutierrez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pomares A, Merino L, Gonzalez S, Morata J, Tonda R, Arribas P, et al.
PLoS One
. 2025 Mar;
20(3):e0318689.
PMID: 40067847
Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous disease characterized by a limited number of molecularly defined subtypes. Recently, genomic-based algorithms have been proposed for the classification of this disease....
2.
Camus V, Thieblemont C, Gaulard P, Cheminant M, Casasnovas R, Ysebaert L, et al.
J Clin Oncol
. 2024 Feb;
42(14):1612-1618.
PMID: 38364196
JCO The primary analysis of the Ro-CHOP phase III randomized controlled trial (ClinicalTrials.gov identifier: NCT01796002) established that romidepsin (Ro) plus cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) did not yield an increased...
3.
Mosquera Orgueira A, Gonzalez Perez M, Diaz Arias J, Rosinol L, Oriol A, Teruel A, et al.
Blood Cancer J
. 2022 Apr;
12(4):76.
PMID: 35468898
The International Staging System (ISS) and the Revised International Staging System (R-ISS) are commonly used prognostic scores in multiple myeloma (MM). These methods have significant gaps, particularly among intermediate-risk groups....
4.
Sancho J, Fernandez-Alvarez R, Gual-Capllonch F, Gonzalez-Garcia E, Grande C, Gutierrez N, et al.
Cancer Med
. 2021 Jan;
10(4):1314-1326.
PMID: 33492774
The use of non-pegylated liposomal doxorubicin (Myocet ) in diffuse large B-cell lymphoma (DLBCL) has been investigated in retrospective and single-arm prospective studies. This was a prospective phase 2 trial...
5.
Garcia-Alvarez M, Alonso-Alvarez S, Prieto-Conde I, Jimenez C, Sarasquete M, Chillon M, et al.
Blood Cancer J
. 2021 Jan;
11(1):11.
PMID: 33431798
No abstract available.
6.
Ruiz-Heredia Y, Sanchez-Vega B, Onecha E, Barrio S, Alonso R, Carlos Martinez-Avila J, et al.
Haematologica
. 2018 Jun;
103(11):e544-e548.
PMID: 29954938
No abstract available.
7.
Moreau P, Cavo M, Sonneveld P, Rosinol L, Attal M, Pezzi A, et al.
J Clin Oncol
. 2014 Jun;
32(20):2173-80.
PMID: 24888806
Purpose: To construct and validate among patients with multiple myeloma (MM) who were treated with intensive therapy a prognostic index of early MM progression-related death. Patients And Methods: Patient-level data...
8.
Jegadeesan R, Liu X, Pagadala M, Gutierrez N, Butt M, Navaneethan U
World J Gastroenterol
. 2013 Jul;
19(26):4252-6.
PMID: 23864791
Lymphocytic and collagenous colitis are forms of microscopic colitis which typically presents in elderly patients as chronic watery diarrhea. The association between microscopic colitis and inflammatory bowel disease is weak...
9.
Mateos M, Oriol A, Martinez-Lopez J, Gutierrez N, Teruel A, Lopez de la Guia A, et al.
Blood
. 2012 Aug;
120(13):2581-8.
PMID: 22889759
Maintenance therapy has become a hot field in myeloma, and it may be particularly relevant in elderly patients because the major benefit results from the initial therapy. We report the...
10.
Mateos M, Oriol A, Martinez-Lopez J, Gutierrez N, Teruel A, de Paz R, et al.
Lancet Oncol
. 2010 Aug;
11(10):934-41.
PMID: 20739218
Background: Bortezomib plus melphalan and prednisone (VMP) is significantly better than melphalan plus prednisone alone for elderly patients with untreated multiple myeloma; however, toxic effects are high. We investigated a...